Schreiber Christopher C 4
4 · Akers Biosciences, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
Schreiber Christopher C
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-01+5,201→ 5,201 total - Exercise/Conversion
Restricted Stock Units
2020-01-01+5,201→ 0 total→ Common Stock (5,201 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company").
- [F2]On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020.